Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186,164,820
-
Total 13F shares
-
81,009,621
-
Share change
-
+10,790,368
-
Total reported value
-
$1,597,454,259
-
Put/Call ratio
-
25%
-
Price per share
-
$19.72
-
Number of holders
-
128
-
Value change
-
+$212,990,118
-
Number of buys
-
90
-
Number of sells
-
33
Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q3 2022
As of 30 Sep 2022,
Revolution Medicines, Inc. - Common Stock (RVMD) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,009,621 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Bellevue Group AG, Column Group LLC, STATE STREET CORP, Nextech Invest AG, BOXER CAPITAL, LLC, PRICE T ROWE ASSOCIATES INC /MD/, TRV GP III, LLC, and BVF INC/IL.
This page lists
130
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.